| Biomarkers of response to immunotherapy in early stage non-small cell lung cancer |
Matthieu Roulleaux Dugage, N. Chaput |
05/01/23
|
European Journal of Cancer |
| Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma |
Marie Breckler, Nathalie Droin |
04/03/23
|
Cancer Discovery |
| Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study |
Cyril Quivoron, Valérie Camara-Clayette, Vincent Ribrag |
04/01/23
|
American Journal of Hematology |
| High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia |
Laure Touchard, Yann Lecluse |
03/01/23
|
Leukemia |
| Intraoperative Autofluorescence Imaging for Parathyroid Gland Identification during Total Laryngectomy with Thyroidectomy † |
Muriel Abbaci |
02/01/23
|
Cancers |
| Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues |
Corinne Dupuy, Anny Slama Schwok |
02/01/23
|
International Journal of Molecular Sciences |
| Serum Metabolome Adaptations Following 12 Weeks of High-Intensity Interval Training or Moderate-Intensity Continuous Training in Obese Older Adults |
Mélanie Bourgin, Sylvère Durand, Fanny Aprahamian, Déborah Lefevre, M. Chiara Maiuri, Guido Kroemer |
02/01/23
|
Metabolites |
| Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle |
Tudor Manoliu, Corinne Laplace-Builhé |
01/10/23
|
Proceedings of the National Academy of Sciences of the United States of America |
| Postoperative radiotherapy in non-small cell lung cancer stage IIIA – N2: Focus and perspectives |
Boris Duchemann |
01/01/23
|
Bulletin du Cancer |
| Molecular analysis for refractory rare cancers: Sequencing battle continues – learnings for the MOSCATO-01 study |
Jean Yves Scoazec |
01/01/23
|
Critical Reviews in Oncology/Hematology |
| Axillary reverse mapping using near-infrared fluorescence imaging in invasive breast cancer (ARMONIC study) |
Muriel Abbaci, Frédéric De Leeuw, Corinne Laplace-Builhé |
12/01/22
|
European Journal of Surgical Oncology |
| Re: Kara N. Maxwell, Heather H. Cheng, Jacquelyn Powers, et al. Inherited TP53 Variants and Risk of Prostate Cancer. Eur Urol 2022;81:243–50: Off-core Li-Fraumeni Syndrome Spectrum Cancers: Increasing Interest for Prostate Cancer? |
Etienne Rouleau |
12/01/22
|
European Urology |
| CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia |
Yann Lecluse |
12/01/22
|
Nature Communications |
| Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform |
Ludovic Lacroix |
12/01/22
|
Scientific Reports |
| De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells |
Olivia Bawa, Jean Yves Scoazec |
12/01/22
|
Molecular Cancer |
| Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers |
Lydie Cassard, Lisa Boselli, Jonathan Grivel, Ludovic Lacroix, N. Chaput |
12/01/22
|
Journal of Experimental and Clinical Cancer Research |
| Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor |
Tudor Manoliu, Valérie Rouffiac, Karine Ser-Le Roux |
12/01/22
|
Stem Cell Research and Therapy |
| Quality assessment in light microscopy for routine use through simple tools and robust metrics |
Tudor Manoliu |
11/07/22
|
Journal of Cell Biology |
| Genomics to select treatment for patients with metastatic breast cancer |
Alicia Tran-Dien |
10/13/22
|
Nature |
| Escherichia coli–Specific CXCL13-Producing T<inf>FH</inf> Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle- Invasive Bladder Cancer |
Virginie Marty, Nicolas Signolle, Jean Yves Scoazec |
10/01/22
|
Cancer Discovery |
